Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), EVP Martin Mackay sold 25,000 shares of Alexion Pharmaceuticals stock on the open market in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $166.42, for a total transaction of $4,160,500.00. Following the transaction, the executive vice president now directly owns 24,426 shares of the company’s stock, valued at approximately $4,064,975. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), net profit margin is 18.60% and weekly performance is -3.80%. On last trading day company shares ended up $163.73. Analysts mean target price for the company is $193.89. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), distance from 50-day simple moving average (SMA50) is 4.07%.
BioDelivery Sciences International, Inc. (NASDAQ:BDSI), Director Francis E. Odonnell, Jr. sold 125,000 shares of BioDelivery Sciences International stock on the open market in a transaction dated Wednesday, June 11th. The shares were sold at an average price of $11.04, for a total value of $1,380,000.00. BioDelivery Sciences International, Inc. (NASDAQ:BDSI), advanced 0.57% in last trading session and ended the day on $12.36. BDSI, Gross Margin is 92.10% and its return on assets is -81.90%. BioDelivery Sciences International, Inc. (NASDAQ:BDSI), quarterly performance is 39.19%.
Acceleron Pharma Inc (NASDAQ:XLRN), CEO John L. Knopf unloaded 15,000 shares of Acceleron Pharma stock in a transaction that occurred on Monday, June 9th. The shares were sold at an average price of $31.65, for a total transaction of $474,750.00. Following the sale, the chief executive officer now directly owns 191,500 shares of the company’s stock, valued at approximately $6,060,975. Acceleron Pharma Inc (NASDAQ:XLRN), shares moved down 1.05% in last trading session and was closed at $33.88, while trading in range of $33.01 – 34.63. Acceleron Pharma Inc (NASDAQ:XLRN), year to date (YTD) performance is -14.44%.
NanoString Technologies Inc (NASDAQ:NSTG), Director Charles P. Waite, Jr. unloaded 166,755 shares of NanoString Technologies stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $15.08, for a total value of $2,514,665.40. NanoString Technologies Inc (NASDAQ:NSTG), ended the last trading day at $15.13. Company weekly volatility is calculated as 4.67% and price to cash ratio as 3.18. NanoString Technologies Inc (NASDAQ:NSTG), showed a negative weekly performance of 1.05%.